The effect of mutation on an aggregation-prone protein: An in vivo, in vitro, and in silico analysis
Open Access
- 25 May 2022
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (22)
Abstract
Aggregation of initially stably structured proteins is involved in more than 20 human amyloid diseases. Despite intense research, however, how this class of proteins assembles into amyloid fibrils remains poorly understood, principally because of the complex effects of amino acid substitutions on protein stability, solubility, and aggregation propensity. We address this question using β 2 -microglobulin (β 2 m) as a model system, focusing on D76N-β 2 m that is involved in hereditary amyloidosis. This amino acid substitution causes the aggregation-resilient wild-type protein to become highly aggregation prone in vitro, although the mechanism by which this occurs remained elusive. Here, we identify the residues key to protecting β 2 m from aggregation by coupling aggregation with antibiotic resistance in E. coli using a tripartite β-lactamase assay (TPBLA). By performing saturation mutagenesis at three different sites (D53X-, D76X-, and D98X-β 2 m) we show that residue 76 has a unique ability to drive β 2 m aggregation in vivo and in vitro. Using a randomly mutated D76N-β 2 m variant library, we show that all of the mutations found to improve protein behavior involve residues in a single aggregation-prone region (APR) (residues 60 to 66). Surprisingly, no correlation was found between protein stability and protein aggregation rate or yield, with several mutations in the APR decreasing aggregation without affecting stability. Together, the results demonstrate the power of the TPBLA to develop proteins that are resilient to aggregation and suggest a model for D76N-β 2 m aggregation involving the formation of long-range couplings between the APR and Asn76 in a nonnative state.Keywords
Funding Information
- Wellcome Trust (204963)
- UKRI | Biotechnology and Biological Sciences Research Council (BB/M012573/1)
- Wellcome Trust (094232)
- Vlaams Instituut voor Biotechnologie (C0401)
- Fonds Wetenschappelijk Onderzoek (G053420N)
- Fonds Wetenschappelijk Onderzoek (S000722N)
- Agence Nationale de la Recherche (ANR/10/LABX/33)
This publication has 62 references indexed in Scilit:
- In vivo detection and quantification of chemicals that enhance protein stabilityAnalytical Biochemistry, 2013
- Optimizing Protein Stability In VivoMolecular Cell, 2009
- Competition between Intramolecular and Intermolecular Interactions in an Amyloid-Forming ProteinJournal of Molecular Biology, 2009
- DE loop mutations affect β2-microglobulin stability and amyloid aggregationBiochemical and Biophysical Research Communications, 2008
- Kinetic Coupling of Folding and Prolyl Isomerization of β2-Microglobulin Studied by Mutational AnalysisJournal of Molecular Biology, 2008
- The Controlling Roles of Trp60 and Trp95 in β2-Microglobulin Function, Folding and Amyloid Aggregation PropertiesJournal of Molecular Biology, 2008
- Protein aggregation and bioprocessingThe AAPS Journal, 2006
- A Comparative Study of the Relationship Between Protein Structure and β-Aggregation in Globular and Intrinsically Disordered ProteinsJournal of Molecular Biology, 2004
- Amyloid-forming Peptides from β2-Microglobulin—Insights into the Mechanism of Fibril Formation in VitroJournal of Molecular Biology, 2002
- The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formationNature Neuroscience, 2001